Norway· NO-ID_82D5B3FC-51E3-45C1-A238-8B3112A84F1C

Intelence

A etravirine product containing etravirine, registered in Norway by Abacus Medicine A/S. The same ATC class is registered in 14 of our 19 countries.

ATC J05AG04

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedIntelenceATCJ05AG04REGISTER NO.NO-ID_82D5B3FC-51E3-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Etravirine is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AG04 (etravirine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose

Etravirine · ATC J05AG04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etravirine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $7.80 in France to $15.34 in Switzerland — a ×2.0 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Etravirine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$15.34
  • FR France$7.80
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Etravirine
Manufacturer
Abacus Medicine A/S
Country
Norway (NO)
ATC code
J05AG04
ATC class
Etravirine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_82D5B3FC-51E3-45C1-A238-8B3112A84F1C
  • no_varenummer
    463085
    60
    NOK 5321.9
  • gtin
    5712440027312

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for etravirine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Etravirine · interactions on record

316 records

  • 33 severe
  • 260 moderate
  • 14 minor

Most severe, free to view

  • DeflazacortH02AB13severe
  • BosutinibL01EA04severe
  • EncorafenibL01EC03severe
  • BrigatinibL01ED04severe

9 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etravirine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etravirine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Intelence
  • Liechtenstein · Intelence

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1fe190e3-b3eb-448d-b3d2-0f5dd8000c78
GET /v1/drugs/1fe190e3-b3eb-448d-b3d2-0f5dd8000c78?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Etravirin",
  "merkevare_id": "ID_82D5B3FC-51E3-45C1-A238-8B3112A84F1C",
  "name_form_strength": "Intelence tab 200 mg",
  "prescription_group": "C"
}

See everything about etravirine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.